Emerging Generic Pharmas Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Emerging Generic Pharmas

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: quasi-geezer who wrote (4)	8/22/2003 12:04:48 PM
From: Tadsamillionaire	of 5

Able Laboratories Gets FDA OK for Tension Headache Drug Friday August 22, 7:49 am ET SOUTH PLAINFIELD, N.J. (Dow Jones)--Able Laboratories Inc. received Food and Drug Administration (News - Websites) approval for a tension headache drug. In a press release Friday, the maker of generic pharmaceuticals said Butalbital Acetaminophen Caffeine and Codeine Phosphate Capsules, 50 milligrams/ 325 mg/40 mg/30 mg, are therapeutically equivalent to Fioricet with Codeine Capsules, produced by Watson Pharmaceuticals Inc. (NYSE:WPI - News) . Able said the total market is estimated to be about $20 million, according to recent market data. The company's shares closed Thursday at $23.41, up 66 cents, or 2.9%, in Nasdaq trading. Company Web site: ablelabs.com SI THREAD AND INFO. Subject 54163

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext